Ethylone

Ethylone

Clinical data
Pregnancy category	N (US)
Routes of administration	Oral, nasal, IV
Legal status
Legal status	BR: Class F2 (Prohibited psychotropics)[1] DE: Anlage I (Authorized scientific use only) UK: Class B UN: Psychotropic Schedule II[2]
Identifiers
IUPAC name (RS)-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one
CAS Number	1112937-64-0 N
PubChem CID	57252245
ChemSpider	21106271 N
UNII	L91C78FW96
KEGG	C22709 N
CompTox Dashboard (EPA)	DTXSID20894842
Chemical and physical data
Formula	C12H15NO3
Molar mass	221.256 g·mol−1
3D model (JSmol)	Interactive image
Chirality	Racemic mixture
SMILES CC(NCC)C(=O)c1ccc2OCOc2c1
InChI InChI=1S/C12H15NO3/c1-3-13-8(2)12(14)9-4-5-10-11(6-9)16-7-15-10/h4-6,8,13H,3,7H2,1-2H3 N Key:MJEMIOXXNCZZFK-UHFFFAOYSA-N N
NY (what is this?)  (verify)

Ethylone, also known as 3,4-methylenedioxy-N-ethylcathinone (MDEC, βk-MDEA), is a recreational designer drug classified as an entactogen, stimulant, and psychedelic of the phenethylamine, amphetamine, and cathinone chemical classes. It is the β-keto analogue of MDEA ("Eve"). Ethylone has only a short history of human use and is reported to be less potent than its relative methylone.^{[citation needed]} In the United States, it began to be found in cathinone products in late 2011.^[3]

Very little data exists about the pharmacological properties, metabolism, and toxicity of ethylone, and although several ethylone-related deaths have been reported, the cause of death was not due to ingestion of ethylone.^[3]